Literature DB >> 15106880

Partial purification and characterization of soluble isoform of butyrylcholinesterase from rat intestine.

Ozlem Yildiz1, Ebru Bodur, A Neşe Cokuğraş, Nazmi Ozer.   

Abstract

Butyrylcholinesterase (BChE; E.C. 3.1.1.8.) was 260-fold purified from soluble fraction of rat intestine. The enzyme was composed of tetrameric globular form by nonreducing electrophoresis. Optimum pH value was determined as 7.2 after zero buffer extrapolation. Optimum temperature was examined as 37 degrees C after zero time extrapolation. The enzyme showed marked substrate activation with positively charged, acyl-choline substrates. As a measure of catalytic efficiency, kcat/Km values were determined as 16,210, 25,650, and 46,150 for acetylthiocholine (ATCh), propionylthiocholine (PTCh), and butyrylthiocholine (BTCh), respectively. When the catalytic efficiencies are compared, soluble isoform of rat intestinal BChE became increasingly efficient as the size of the acyl portion of the substrate increases; BTCh > PTCh > ATCh. Differently, the enzyme showed substrate inhibition with benzoylcholine (BzCh) and a kcat/Km value of 21,190 was found. Triton X-100 inhibited more efficiently the rat intestinal BChE soluble isoform than it did the human serum BChE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106880     DOI: 10.1023/b:jopc.0000020081.36183.b8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  26 in total

1.  The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.

Authors:  L Raveh; E Grauer; J Grunwald; E Cohen; Y Ashani
Journal:  Toxicol Appl Pharmacol       Date:  1997-07       Impact factor: 4.219

2.  Electrostatic interactions of the butyrylcholinesterase dimer of mucosal cells of rat intestine with glycosaminoglycans.

Authors:  J P Sine; B Colas
Journal:  Int J Biochem Cell Biol       Date:  1996-05       Impact factor: 5.085

Review 3.  Calcium-binding sites in proteins: a structural perspective.

Authors:  C A McPhalen; N C Strynadka; M N James
Journal:  Adv Protein Chem       Date:  1991

4.  Substrate activation in acetylcholinesterase induced by low pH or mutation in the pi-cation subsite.

Authors:  Patrick Masson; Lawrence M Schopfer; Cynthia F Bartels; Marie-Thérèse Froment; Fabien Ribes; Florian Nachon; Oksana Lockridge
Journal:  Biochim Biophys Acta       Date:  2002-02-11

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  The plasma cholinesteerases: a new perspective.

Authors:  S S Brown; W Kalow; W Pilz; M Whittaker; C L Woronick
Journal:  Adv Clin Chem       Date:  1981       Impact factor: 5.394

7.  Effects of mutations of active site residues and amino acids interacting with the Omega loop on substrate activation of butyrylcholinesterase.

Authors:  P Masson; W Xie; M T Froment; O Lockridge
Journal:  Biochim Biophys Acta       Date:  2001-01-12

8.  Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice.

Authors:  R S Hoffman; R Morasco; L R Goldfrank
Journal:  J Toxicol Clin Toxicol       Date:  1996

9.  DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.

Authors:  Andreea Ticu Boeck; Lawrence M Schopfer; Oksana Lockridge
Journal:  Biochem Pharmacol       Date:  2002-06-15       Impact factor: 5.858

10.  Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters.

Authors:  P Masson; M T Froment; P L Fortier; J E Visicchio; C F Bartels; O Lockridge
Journal:  Biochim Biophys Acta       Date:  1998-09-08
View more
  1 in total

1.  Purification and kinetic properties of 6-phosphogluconate dehydrogenase from rat small intestine.

Authors:  Deniz Ceyhan; Ali Danişan; I Hamdi Oğüş; Nazmi Ozer
Journal:  Protein J       Date:  2005-07       Impact factor: 2.371

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.